Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Galecto | Damora Therapeutics

Biotech & Life Sciences · Copenhagen, Denmark · Founded 2011 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.60B
Market cap · Apr/2026

Investors

33 investors on Galecto | Damora Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 4 investors entered at this stage
Novo Seeds
Seed Capital
M Ventures
Sunstone Life Science Ventures
Series B+ 29 investors entered at this stage
Andreessen Horowitz
Blackstone
Commodore Capital
Asymmetry capital management
Janus Henderson Investors
Lund University
Balyasny Asset Management
Novo Holdings
BB Biotech
Canica
OrbiMed
Forbion Capital Partners
Cormorant Asset Management
Fairmount Partners
Eir Ventures
RA Capital Management
Venrock
Maverick Ventures
Perceptive Advisors
Soleus Capital
TCGX
Wellington Management
Seventure Partners
Bristol-Myers Squibb
Sphera
Viking Global Investors
Vestal Point Capital
Ysios Capital
Hadean Ventures

Global footprint

Where Galecto | Damora Therapeutics has talent and traffic

Web traffic by country
1.7K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

See Galecto | Damora Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo